What's in Cathleen McCabe MD's pipeline?

Cathleen McCabe MD has 1 drugs in our index: 1 marketed, 0 filed, 0 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with Cathleen McCabe MD's portfolio?

Top competitors by shared drug class: Ache Laboratorios Farmaceuticos S.A., Al-Azhar University, All India Institute of Medical Sciences, Bhubaneswar, Apotex Inc., Astellas Pharma Inc.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/cathleen-mccabe-md.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-17 · How we verify

Cathleen McCabe MD — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Cathleen McCabe MD pipeline: 1 marketed, 0 filed, 0 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

1 marketed 0 filed 0 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
Durezol 0.05% Ophthalmic Emulsion	Durezol 0.05% Ophthalmic Emulsion	marketed	Topical corticosteroid	Glucocorticoid receptor	Ophthalmology

Therapeutic area mix

Ophthalmology · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Ache Laboratorios Farmaceuticos S.A. · 1 shared drug class
Al-Azhar University · 1 shared drug class
All India Institute of Medical Sciences, Bhubaneswar · 1 shared drug class
Apotex Inc. · 1 shared drug class
Astellas Pharma Inc · 1 shared drug class
Astion Pharma A/S · 1 shared drug class
AstraZeneca · 1 shared drug class
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Cathleen McCabe MD:

Cite this brief

Drug Landscape (2026). Cathleen McCabe MD — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/cathleen-mccabe-md. Accessed 2026-05-17.